Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Mirati Therapeutics revenue
Mirati Therapeutics's revenue is $12.4 million.
What is Mirati Therapeutics's revenue?
- Mirati Therapeutics's revenue growth from 2018 to 2022 is -3.79%.
- Mirati Therapeutics has 418 employees, and the revenue per employee ratio is $29,751.
- Mirati Therapeutics's peak quarterly revenue was $71.8M in 2021(q3).
- Mirati Therapeutics peak revenue was $72.1M in 2021.
- Mirati Therapeutics annual revenue for 2021 was 72.1M, 438.08% growth from 2020.
- Mirati Therapeutics annual revenue for 2022 was 12.4M, -82.75% growth from 2021.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Mirati Therapeutics historical revenue
Mirati Therapeutics's peak revenue was $72.1M in 2021. The peak quarterly revenue was $71.8M in 2021(q3).
Mirati Therapeutics's revenue increased from $12.9m in 2018 to $12.4M currently. That's a -3.79% change in annual revenue.
Mirati Therapeutics annual revenue
Mirati Therapeutics annual revenue over time
| Fiscal year / year | Mirati Therapeutics revenue |
|---|---|
| 2018 | $12.9M |
| 2019 | $3.3M |
| 2020 | $13.4M |
| 2021 | $72.1M |
| 2022 | $12.4M |
How accurately did Mirati Therapeutics' revenue projections match actual performance?
Mirati Therapeutics annual growth
Mirati Therapeutics saw the greatest revenue growth in 2021, when revenue increased by 438.08%.
Mirati Therapeutics had the lowest revenue growth in 2022, when revenue changed by -82.75%.
Mirati Therapeutics annual growth rate over time
| Year | Mirati Therapeutics growth |
|---|---|
| 2019 | -74%↓ |
| 2020 | 302%↑ |
| 2021 | 438%↑ |
| 2022 | -83%↓ |
Mirati Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Mirati Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | $9.5M | - | - | $3.5M |
| 2019 | $1.2M | $577,000 | $988,000 | $526,000 |
| 2020 | $267,000 | - | $11.4M | $1.7M |
| 2021 | - | - | $71.8M | $299,000 |
| 2022 | $709,000 | $5.4M | $5.4M | $934,000 |
| 2023 | $7.2M | $13.7M | $16.4M | - |
Mirati Therapeutics jobs nearby
Do you work at Mirati Therapeutics?
Is Mirati Therapeutics transparent about its revenue structure?
Mirati Therapeutics financial information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 418 |
| Date Founded | 1995 |
| Headquarters | San Diego, California |
| Number of Locations | 1 |
| Revenue | $12.4M |
| Net Income | -$740,867,000 |
| Gross Proft | $11.8M (2022) |
| Tax Rate | -0.0% |
| Total Assets | $1,202,647,000 |
| Ticker | MRTX |
Mirati Therapeutics jobs you might like
Mirati Therapeutics financing
Mirati Therapeutics received early financing of $234.3M on 2019-06-28.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $234.3M | 06/2019 |
| Post Ipo Equity | $345M | 01/2020 |
| Post Ipo Equity | $926.3M | 10/2020 |
| Post Ipo Equity | $500M | 11/2021 |
Mirati Therapeutics competitors
Mirati Therapeutics's top competitor, Clovis Oncology, earned an annual revenue of $148.8M.
Mirati Therapeutics's smallest competitor is Onconova Therapeutics with revenue of $226.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Clovis Oncology | - | $148.8M | 468 | - |
| Tango Therapeutics | - | $42.1M | 91 | - |
| Salarius Pharmaceuticals | - | $5.2M | 5 | - |
| Cyteir Therapeutics | - | $1.6M | 26 | - |
| Oncternal Therapeutics | - | $785,000 | 13 | - |
| G1 Therapeutics | - | $82.5M | 148 | - |
| Onconova Therapeutics | - | $226,000 | 12 | - |
| IDEAYA Biosciences | - | $7.0M | 69 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Mirati Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Mirati Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Mirati Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Mirati Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Mirati Therapeutics. The data presented on this page does not represent the view of Mirati Therapeutics and its employees or that of Zippia.
Mirati Therapeutics may also be known as or be related to MIRATI THERAPEUTICS INC., Mirati Therapeutics, Mirati Therapeutics Inc, Mirati Therapeutics Inc. and Mirati Therapeutics, Inc.